PubRank
Search
About
Rosario Maselli
Author PubWeight™ 17.43
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
The potential of biologics for the treatment of asthma.
Nat Rev Drug Discov
2012
1.11
2
Molecular mechanisms underlying airway smooth muscle contraction and proliferation: implications for asthma.
Respir Med
2008
1.07
3
Alpha-interferon and its effects on signal transduction pathways.
J Cell Physiol
2005
1.07
4
Mitogen-activated protein kinases and asthma.
J Cell Physiol
2005
1.04
5
Update on anticytokine treatment for asthma.
Biomed Res Int
2013
0.92
6
Effects of TGF-beta and glucocorticoids on map kinase phosphorylation, IL-6/IL-11 secretion and cell proliferation in primary cultures of human lung fibroblasts.
J Cell Physiol
2007
0.89
7
Effects of transforming growth factor-[beta] and budesonide on mitogen-activated protein kinase activation and apoptosis in airway epithelial cells.
Am J Respir Cell Mol Biol
2003
0.89
8
Endothelin-1 induces proliferation of human lung fibroblasts and IL-11 secretion through an ET(A) receptor-dependent activation of MAP kinases.
J Cell Biochem
2005
0.88
9
Effects of hydrogen peroxide on MAPK activation, IL-8 production and cell viability in primary cultures of human bronchial epithelial cells.
J Cell Biochem
2004
0.87
10
Respiratory infections and asthma.
Respir Med
2005
0.86
11
Effects of simvastatin on cell viability and proinflammatory pathways in lung adenocarcinoma cells exposed to hydrogen peroxide.
BMC Pharmacol Toxicol
2014
0.85
12
Update on optimal use of omalizumab in management of asthma.
J Asthma Allergy
2011
0.83
13
Levofloxacin-induced taste perversion, blurred vision and dyspnoea in a young woman.
Clin Drug Investig
2004
0.81
14
Treatment of chronic obstructive pulmonary disease by dual bronchodilation with coformulation of indacaterol/glycopyrronium.
Pharmacology
2014
0.81
15
Peptidome profiling of induced sputum by mesoporous silica beads and MALDI-TOF MS for non-invasive biomarker discovery of chronic inflammatory lung diseases.
Proteomics
2011
0.80
16
Omalizumab in the treatment of severe asthma: efficacy and current problems.
Ther Adv Respir Dis
2008
0.79
17
Ascaris lumbricoides-induced suppression of total and specific IgE responses in atopic subjects is interleukin 10-independent and associated with an increase of CD25(+) cells.
Diagn Microbiol Infect Dis
2008
0.79
18
Effects of ambrisentan in a patient affected by combined pulmonary fibrosis and emphysema and by severe pulmonary hypertension: clinical, functional, and biomolecular findings.
Clin Drug Investig
2013
0.77
19
Pharmacological basis and scientific rationale underlying the targeted use of inhaled corticosteroid/long-acting β2-adrenergic agonist combinations in chronic obstructive pulmonary disease treatment.
Expert Opin Pharmacother
2015
0.75
20
Biological targets for therapeutic interventions in COPD: clinical potential.
Int J Chron Obstruct Pulmon Dis
2006
0.75
21
Potential genetic influences on the response to asthma treatment.
Pulm Pharmacol Ther
2004
0.75